🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Top 6 Research Reports For July 7, 2016

Published 07/07/2016, 01:06 AM
Updated 10/23/2024, 11:45 AM
CVX
-
BP
-
EXPE
-
MCK
-
AIZ
-
BXP
-
WMB
-
TRIP
-

Thursday, July 7, 2016

Today's must-read reports are for Expedia (NASDAQ:EXPE) (EXPE), BP (LON:BP) (BP) and McKesson (NYSE:MCK) (MCK).

Despite languishing in the red year-to-date, shares of Expedia have notched up gains over the last quarter. This Zacks Rank # 1 (Strong Buy) rated stock continues to benefit from strong travel market trends. The analyst likes the company's prudent growth plan, a solid travel booking platform, contribution from a series of acquisitions, the Ctrip deal and management execution. (You can read the full research report on EXPE here.)

Zacks Rank # 2 (Buy) rated BP shares have gained nicely this year on the back of the oil price rebound. But the company's continued underperformance of its super-major peers likely reflects that management hasn't fully regained the market's trust following the Gulf of Mexico tragedy of a few years back. This lingering issue notwithstanding, our analyst likes BP’s long-term cost cutting plan and strategy of offloading non-core upstream properties. (You can read the full research report on BP here.)

McKesson’s shares have gained nearly 18% over the last three months. Estimates for this Zacks Rank # 2 (Buy) stock have been moving up lately given favorable trends in its distribution solutions segment, which has held up strongly despite weak pricing trends and customer consolidation. The analyst likes McKesson’s strategy of pursuing deals and acquisitions to drive growth, with the recent Celesio deal expected to strengthen McKesson’s foothold in Europe. (You can read the full research report on MCK here.)

Other noteworthy reports we are featuring today include Chevron (NYSE:CVX) (CVX), Avon (AVP) and Ventas (VTR).

You can find all of today's stock research reports here.

Note: Sheraz Mian regularly provides earnings analysis on Zacks.com and appears frequently in the print and electronic media. His weekly earnings related articles include Earnings Trends and Earnings Preview. He also provides weekly commentary to Zacks Premium subscribers and manages the Zacks Focus List and Top 10 portfolios. If you want an email notification each time Sheraz publishes a new article, please click here.

Featured Reports

Chevron (CVX) Commits to $37B Kazakh Oilfield Expansion

Chevron's approval of the expansion of Kazakhstan's Tengiz oilfield is an important landmark for the company, which considers the country crucial for its business, according to the Zacks analyst.

Becton, Dickinson (BDX) Bets on Expanding Product Portfolio

The covering analyst thinks Becton, Dickinson's expanding product portfolio based on recent regulatory approvals is a major positive.

FactSet (FDS) Completes Assets Sale, Updates Q4 View

The Zacks analyst believes FactSet's recently completed divestments will help it in focusing on higher margin businesses.

Assurant (NYSE:AIZ) Gains from American Title Buy

The Zacks analyst believes the acquisition will strengthen Assurant's capabilities in the housing market even as it projects the transaction to be accretive to earnings next year.

Ventas (VTR) Signs $1.5 Billion Life-Sciences Real Estate Deal

Ventas' deal to acquire life science and medical real estate assets from Wexford marks its entry into the growing university-affiliated life science real estate business.

Boston Properties (NYSE:BXP) Completes Colorado Center Stake Buyout

Boston Properties recently obtained a 49.8% stake in the Colorado Center in Santa Monica, CA. which is the company's first foray into the expanding Westside Los Angeles market.

TripAdvisor (TRIP) Appoints Gary Fritz as Chief Growth Officer

TripAdvisor Inc (NASDAQ:TRIP). appointed Gary Fritz as its chief growth officer and president of its Asia-Pacific operations to help implement formulated strategies across all brands.

New Upgrades

DeVry's (DV) Health Care and International Segments Support Sales

The Zacks analyst believes DeVry's Medical & Healthcare and International and Professional Education segments will do well in the upcoming quarter due to robust demand and campus expansions.

ON Smart Media Platform to Drive Outfront's (OUT) Growth

Outfront has expanded this platform in Minneapolis and St. Paul skyway systems, which is likely to re-define the advertising experience of consumers, according to the covering analyst.

Williams' (WMB) Large-Scale Projects to Rake in High Returns

The Zacks analyst thinks Williams Companies (NYSE:WMB)' large-scale value-creating projects position it for strong returns even in a low commodity price environment.

New Downgrades

Avon (AVP) Continues to Fight Currency Woes

The covering analyst stresses that Avon's significant international presence means it is exposed to adverse foreign currency fluctuations, which are expected to linger in 2016 and impact results.

Weyerhaeuser's (WY) Potential Dims on Near-Term Concerns

The Zacks analyst believes Weyerhaeuser's exposure to risks like geopolitical issues, forex movements, uncertain economic conditions and stiff market competition remain prime causes of concern.

Medivation's (MDVN) Dependence on Xtandi's Performance Worrying

While prostate cancer treatment, Xtandi, does represent huge commercial potential, any slowdown in Xtandi sales would have a negative impact on the shares, according to the Zacks analyst



VENTAS INC (VTR): Free Stock Analysis Report

MCKESSON CORP (MCK): Free Stock Analysis Report

EXPEDIA INC (EXPE): Free Stock Analysis Report

CHEVRON CORP (CVX): Free Stock Analysis Report

BP PLC (BP): Free Stock Analysis Report

AVON PRODS INC (AVP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.